nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylpropanolamine—ADRB2—Levobunolol—glaucoma	0.0715	0.0853	CbGbCtD
Phenylpropanolamine—ADRB2—Metipranolol—glaucoma	0.0715	0.0853	CbGbCtD
Phenylpropanolamine—ADRB1—Levobunolol—glaucoma	0.0704	0.084	CbGbCtD
Phenylpropanolamine—ADRB1—Metipranolol—glaucoma	0.0704	0.084	CbGbCtD
Phenylpropanolamine—ADRB2—Carteolol—glaucoma	0.0608	0.0725	CbGbCtD
Phenylpropanolamine—ADRB1—Carteolol—glaucoma	0.0599	0.0714	CbGbCtD
Phenylpropanolamine—ADRB2—Dipivefrin—glaucoma	0.0433	0.0517	CbGbCtD
Phenylpropanolamine—ADRB2—Betaxolol—glaucoma	0.0411	0.049	CbGbCtD
Phenylpropanolamine—ADRA2A—Brimonidine—glaucoma	0.0409	0.0488	CbGbCtD
Phenylpropanolamine—ADRA2A—Apraclonidine—glaucoma	0.0409	0.0488	CbGbCtD
Phenylpropanolamine—ADRB1—Betaxolol—glaucoma	0.0404	0.0483	CbGbCtD
Phenylpropanolamine—ADRA1A—Apraclonidine—glaucoma	0.0392	0.0467	CbGbCtD
Phenylpropanolamine—ADRA2A—Dipivefrin—glaucoma	0.0327	0.039	CbGbCtD
Phenylpropanolamine—ADRA1A—Dipivefrin—glaucoma	0.0313	0.0374	CbGbCtD
Phenylpropanolamine—ADRB2—Timolol—glaucoma	0.0265	0.0316	CbGbCtD
Phenylpropanolamine—ADRB1—Timolol—glaucoma	0.0261	0.0311	CbGbCtD
Phenylpropanolamine—SLC6A2—Clonidine—glaucoma	0.0188	0.0225	CbGbCtD
Phenylpropanolamine—ADRA2A—Clonidine—glaucoma	0.017	0.0202	CbGbCtD
Phenylpropanolamine—ADRA1A—Clonidine—glaucoma	0.0163	0.0194	CbGbCtD
Phenylpropanolamine—CYP1A2—Betaxolol—glaucoma	0.0125	0.0149	CbGbCtD
Phenylpropanolamine—CYP1A2—Clonidine—glaucoma	0.00685	0.00817	CbGbCtD
Phenylpropanolamine—ADRB2—Treprostinil—Latanoprost—glaucoma	0.00221	1	CbGdCrCtD
Phenylpropanolamine—Hypersensitivity—Dipivefrin—glaucoma	0.000979	0.00828	CcSEcCtD
Phenylpropanolamine—Irritability—Apraclonidine—glaucoma	0.000941	0.00797	CcSEcCtD
Phenylpropanolamine—Nausea—Physostigmine—glaucoma	0.000928	0.00786	CcSEcCtD
Phenylpropanolamine—Tension—Metipranolol—glaucoma	0.000898	0.0076	CcSEcCtD
Phenylpropanolamine—Nervousness—Metipranolol—glaucoma	0.000888	0.00752	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Carteolol—glaucoma	0.00087	0.00736	CcSEcCtD
Phenylpropanolamine—Flushing—Carbachol—glaucoma	0.000867	0.00734	CcSEcCtD
Phenylpropanolamine—Vision blurred—Metipranolol—glaucoma	0.000862	0.0073	CcSEcCtD
Phenylpropanolamine—Irritability—Acetazolamide—glaucoma	0.000842	0.00712	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Carbachol—glaucoma	0.000835	0.00706	CcSEcCtD
Phenylpropanolamine—Ataxia—Acetazolamide—glaucoma	0.000829	0.00702	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Levobunolol—glaucoma	0.000822	0.00696	CcSEcCtD
Phenylpropanolamine—Tension—Diclofenamide—glaucoma	0.000818	0.00692	CcSEcCtD
Phenylpropanolamine—Nervousness—Diclofenamide—glaucoma	0.000809	0.00685	CcSEcCtD
Phenylpropanolamine—Vision blurred—Carteolol—glaucoma	0.000799	0.00676	CcSEcCtD
Phenylpropanolamine—Tremor—Diclofenamide—glaucoma	0.000781	0.00661	CcSEcCtD
Phenylpropanolamine—Anxiety—Metipranolol—glaucoma	0.000776	0.00657	CcSEcCtD
Phenylpropanolamine—Irritability—Brinzolamide—glaucoma	0.000758	0.00642	CcSEcCtD
Phenylpropanolamine—Vision blurred—Latanoprost—glaucoma	0.0007	0.00592	CcSEcCtD
Phenylpropanolamine—Confusional state—Diclofenamide—glaucoma	0.000686	0.0058	CcSEcCtD
Phenylpropanolamine—Drowsiness—Acetazolamide—glaucoma	0.00068	0.00575	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Metipranolol—glaucoma	0.000666	0.00563	CcSEcCtD
Phenylpropanolamine—Somnolence—Metipranolol—glaucoma	0.000664	0.00562	CcSEcCtD
Phenylpropanolamine—Confusional state—Levobunolol—glaucoma	0.000659	0.00558	CcSEcCtD
Phenylpropanolamine—Drowsiness—Brimonidine—glaucoma	0.000652	0.00552	CcSEcCtD
Phenylpropanolamine—Hypotension—Carteolol—glaucoma	0.000646	0.00547	CcSEcCtD
Phenylpropanolamine—Confusional state—Methazolamide—glaucoma	0.000631	0.00534	CcSEcCtD
Phenylpropanolamine—Insomnia—Carteolol—glaucoma	0.000626	0.0053	CcSEcCtD
Phenylpropanolamine—Hypotension—Carbachol—glaucoma	0.00062	0.00525	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Carteolol—glaucoma	0.000617	0.00522	CcSEcCtD
Phenylpropanolamine—Hypotension—Levobunolol—glaucoma	0.000611	0.00517	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Apraclonidine—glaucoma	0.000609	0.00516	CcSEcCtD
Phenylpropanolamine—Somnolence—Diclofenamide—glaucoma	0.000605	0.00512	CcSEcCtD
Phenylpropanolamine—Blood pressure increased—Timolol—glaucoma	0.000598	0.00506	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Levobunolol—glaucoma	0.000583	0.00493	CcSEcCtD
Phenylpropanolamine—Tension—Apraclonidine—glaucoma	0.000583	0.00493	CcSEcCtD
Phenylpropanolamine—Irritability—Clonidine—glaucoma	0.000582	0.00493	CcSEcCtD
Phenylpropanolamine—Constipation—Diclofenamide—glaucoma	0.000581	0.00492	CcSEcCtD
Phenylpropanolamine—Urinary retention—Clonidine—glaucoma	0.00058	0.00491	CcSEcCtD
Phenylpropanolamine—Nervousness—Apraclonidine—glaucoma	0.000577	0.00488	CcSEcCtD
Phenylpropanolamine—Flushing—Acetazolamide—glaucoma	0.000566	0.00479	CcSEcCtD
Phenylpropanolamine—Tension—Bimatoprost—glaucoma	0.000565	0.00478	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Diclofenamide—glaucoma	0.00056	0.00474	CcSEcCtD
Phenylpropanolamine—Vision blurred—Apraclonidine—glaucoma	0.000559	0.00474	CcSEcCtD
Phenylpropanolamine—Nervousness—Bimatoprost—glaucoma	0.000559	0.00473	CcSEcCtD
Phenylpropanolamine—Somnolence—Methazolamide—glaucoma	0.000557	0.00471	CcSEcCtD
Phenylpropanolamine—Hallucination—Dorzolamide—glaucoma	0.000556	0.00471	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Metipranolol—glaucoma	0.00055	0.00466	CcSEcCtD
Phenylpropanolamine—Flushing—Brimonidine—glaucoma	0.000543	0.0046	CcSEcCtD
Phenylpropanolamine—Vision blurred—Bimatoprost—glaucoma	0.000542	0.00459	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Latanoprost—glaucoma	0.00054	0.00457	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Levobunolol—glaucoma	0.000539	0.00456	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Brimonidine—glaucoma	0.000523	0.00443	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Betaxolol—glaucoma	0.000519	0.00439	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Methazolamide—glaucoma	0.000516	0.00437	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Carteolol—glaucoma	0.00051	0.00431	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Dorzolamide—glaucoma	0.0005	0.00423	CcSEcCtD
Phenylpropanolamine—Ataxia—Betaxolol—glaucoma	0.000499	0.00423	CcSEcCtD
Phenylpropanolamine—Dizziness—Metipranolol—glaucoma	0.000494	0.00418	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Brinzolamide—glaucoma	0.000491	0.00416	CcSEcCtD
Phenylpropanolamine—Flushing—Pilocarpine—glaucoma	0.00049	0.00415	CcSEcCtD
Phenylpropanolamine—Anxiety—Bimatoprost—glaucoma	0.000488	0.00413	CcSEcCtD
Phenylpropanolamine—Agitation—Acetazolamide—glaucoma	0.000488	0.00413	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Levobunolol—glaucoma	0.000482	0.00408	CcSEcCtD
Phenylpropanolamine—Vision blurred—Brimonidine—glaucoma	0.00048	0.00407	CcSEcCtD
Phenylpropanolamine—Tension—Dorzolamide—glaucoma	0.000478	0.00404	CcSEcCtD
Phenylpropanolamine—Nervousness—Dorzolamide—glaucoma	0.000473	0.004	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Pilocarpine—glaucoma	0.000472	0.004	CcSEcCtD
Phenylpropanolamine—Rash—Metipranolol—glaucoma	0.000471	0.00398	CcSEcCtD
Phenylpropanolamine—Dermatitis—Metipranolol—glaucoma	0.00047	0.00398	CcSEcCtD
Phenylpropanolamine—Drowsiness—Clonidine—glaucoma	0.00047	0.00398	CcSEcCtD
Phenylpropanolamine—Tension—Brinzolamide—glaucoma	0.00047	0.00398	CcSEcCtD
Phenylpropanolamine—Nervousness—Brinzolamide—glaucoma	0.000465	0.00393	CcSEcCtD
Phenylpropanolamine—Vision blurred—Dorzolamide—glaucoma	0.000459	0.00388	CcSEcCtD
Phenylpropanolamine—Dizziness—Carteolol—glaucoma	0.000457	0.00387	CcSEcCtD
Phenylpropanolamine—Vision blurred—Travoprost—glaucoma	0.000457	0.00387	CcSEcCtD
Phenylpropanolamine—Tension—Pilocarpine—glaucoma	0.000451	0.00382	CcSEcCtD
Phenylpropanolamine—Vision blurred—Brinzolamide—glaucoma	0.000451	0.00382	CcSEcCtD
Phenylpropanolamine—Dizziness—Diclofenamide—glaucoma	0.00045	0.00381	CcSEcCtD
Phenylpropanolamine—Tremor—Brinzolamide—glaucoma	0.000448	0.0038	CcSEcCtD
Phenylpropanolamine—Nervousness—Pilocarpine—glaucoma	0.000447	0.00378	CcSEcCtD
Phenylpropanolamine—Nausea—Metipranolol—glaucoma	0.000443	0.00375	CcSEcCtD
Phenylpropanolamine—Agitation—Brinzolamide—glaucoma	0.00044	0.00372	CcSEcCtD
Phenylpropanolamine—Dizziness—Carbachol—glaucoma	0.000439	0.00372	CcSEcCtD
Phenylpropanolamine—Insomnia—Apraclonidine—glaucoma	0.000438	0.00371	CcSEcCtD
Phenylpropanolamine—Confusional state—Acetazolamide—glaucoma	0.000437	0.0037	CcSEcCtD
Phenylpropanolamine—Vision blurred—Pilocarpine—glaucoma	0.000433	0.00367	CcSEcCtD
Phenylpropanolamine—Anxiety—Brimonidine—glaucoma	0.000432	0.00366	CcSEcCtD
Phenylpropanolamine—Vomiting—Diclofenamide—glaucoma	0.000432	0.00366	CcSEcCtD
Phenylpropanolamine—Dizziness—Levobunolol—glaucoma	0.000432	0.00366	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Apraclonidine—glaucoma	0.000432	0.00366	CcSEcCtD
Phenylpropanolamine—Tremor—Pilocarpine—glaucoma	0.000431	0.00365	CcSEcCtD
Phenylpropanolamine—Somnolence—Apraclonidine—glaucoma	0.000431	0.00365	CcSEcCtD
Phenylpropanolamine—Rash—Diclofenamide—glaucoma	0.000429	0.00363	CcSEcCtD
Phenylpropanolamine—Insomnia—Bimatoprost—glaucoma	0.000425	0.0036	CcSEcCtD
Phenylpropanolamine—Agitation—Pilocarpine—glaucoma	0.000423	0.00358	CcSEcCtD
Phenylpropanolamine—Vomiting—Carbachol—glaucoma	0.000422	0.00357	CcSEcCtD
Phenylpropanolamine—Hallucination—Clonidine—glaucoma	0.00042	0.00355	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Bimatoprost—glaucoma	0.000419	0.00355	CcSEcCtD
Phenylpropanolamine—Rash—Carbachol—glaucoma	0.000418	0.00354	CcSEcCtD
Phenylpropanolamine—Dermatitis—Carbachol—glaucoma	0.000418	0.00354	CcSEcCtD
Phenylpropanolamine—Somnolence—Bimatoprost—glaucoma	0.000418	0.00354	CcSEcCtD
Phenylpropanolamine—Constipation—Apraclonidine—glaucoma	0.000414	0.00351	CcSEcCtD
Phenylpropanolamine—Anxiety—Dorzolamide—glaucoma	0.000413	0.0035	CcSEcCtD
Phenylpropanolamine—Anxiety—Travoprost—glaucoma	0.000411	0.00348	CcSEcCtD
Phenylpropanolamine—Nausea—Carteolol—glaucoma	0.000411	0.00348	CcSEcCtD
Phenylpropanolamine—Tachycardia—Brimonidine—glaucoma	0.000406	0.00344	CcSEcCtD
Phenylpropanolamine—Nausea—Diclofenamide—glaucoma	0.000404	0.00342	CcSEcCtD
Phenylpropanolamine—Dizziness—Latanoprost—glaucoma	0.000401	0.00339	CcSEcCtD
Phenylpropanolamine—Confusional state—Dorzolamide—glaucoma	0.000401	0.00339	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Apraclonidine—glaucoma	0.000399	0.00338	CcSEcCtD
Phenylpropanolamine—Vomiting—Methazolamide—glaucoma	0.000398	0.00337	CcSEcCtD
Phenylpropanolamine—Rash—Methazolamide—glaucoma	0.000395	0.00334	CcSEcCtD
Phenylpropanolamine—Dermatitis—Methazolamide—glaucoma	0.000394	0.00334	CcSEcCtD
Phenylpropanolamine—Nausea—Carbachol—glaucoma	0.000394	0.00334	CcSEcCtD
Phenylpropanolamine—Anxiety—Pilocarpine—glaucoma	0.00039	0.0033	CcSEcCtD
Phenylpropanolamine—Hypotension—Brimonidine—glaucoma	0.000389	0.00329	CcSEcCtD
Phenylpropanolamine—Nausea—Levobunolol—glaucoma	0.000388	0.00329	CcSEcCtD
Phenylpropanolamine—Tachycardia—Travoprost—glaucoma	0.000386	0.00327	CcSEcCtD
Phenylpropanolamine—Somnolence—Acetazolamide—glaucoma	0.000385	0.00326	CcSEcCtD
Phenylpropanolamine—Rash—Latanoprost—glaucoma	0.000382	0.00323	CcSEcCtD
Phenylpropanolamine—Dermatitis—Latanoprost—glaucoma	0.000382	0.00323	CcSEcCtD
Phenylpropanolamine—Tachycardia—Brinzolamide—glaucoma	0.000381	0.00323	CcSEcCtD
Phenylpropanolamine—Confusional state—Pilocarpine—glaucoma	0.000378	0.0032	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Clonidine—glaucoma	0.000377	0.00319	CcSEcCtD
Phenylpropanolamine—Insomnia—Brimonidine—glaucoma	0.000376	0.00318	CcSEcCtD
Phenylpropanolamine—Nausea—Methazolamide—glaucoma	0.000372	0.00315	CcSEcCtD
Phenylpropanolamine—Hypotension—Dorzolamide—glaucoma	0.000371	0.00314	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Brimonidine—glaucoma	0.000371	0.00314	CcSEcCtD
Phenylpropanolamine—Somnolence—Brimonidine—glaucoma	0.00037	0.00313	CcSEcCtD
Phenylpropanolamine—Hypotension—Travoprost—glaucoma	0.00037	0.00313	CcSEcCtD
Phenylpropanolamine—Tachycardia—Pilocarpine—glaucoma	0.000366	0.0031	CcSEcCtD
Phenylpropanolamine—Hallucination—Betaxolol—glaucoma	0.000365	0.00309	CcSEcCtD
Phenylpropanolamine—Hypotension—Brinzolamide—glaucoma	0.000365	0.00309	CcSEcCtD
Phenylpropanolamine—Tension—Clonidine—glaucoma	0.00036	0.00305	CcSEcCtD
Phenylpropanolamine—Insomnia—Dorzolamide—glaucoma	0.000359	0.00304	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Acetazolamide—glaucoma	0.000357	0.00302	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Apraclonidine—glaucoma	0.000357	0.00302	CcSEcCtD
Phenylpropanolamine—Nervousness—Clonidine—glaucoma	0.000357	0.00302	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Dorzolamide—glaucoma	0.000354	0.003	CcSEcCtD
Phenylpropanolamine—Insomnia—Brinzolamide—glaucoma	0.000353	0.00299	CcSEcCtD
Phenylpropanolamine—Somnolence—Dorzolamide—glaucoma	0.000353	0.00299	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Travoprost—glaucoma	0.000353	0.00299	CcSEcCtD
Phenylpropanolamine—Hypotension—Pilocarpine—glaucoma	0.000351	0.00297	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Brinzolamide—glaucoma	0.000348	0.00295	CcSEcCtD
Phenylpropanolamine—Somnolence—Brinzolamide—glaucoma	0.000347	0.00294	CcSEcCtD
Phenylpropanolamine—Vision blurred—Clonidine—glaucoma	0.000346	0.00293	CcSEcCtD
Phenylpropanolamine—Tremor—Clonidine—glaucoma	0.000344	0.00291	CcSEcCtD
Phenylpropanolamine—Flushing—Betaxolol—glaucoma	0.000341	0.00289	CcSEcCtD
Phenylpropanolamine—Insomnia—Pilocarpine—glaucoma	0.00034	0.00287	CcSEcCtD
Phenylpropanolamine—Constipation—Travoprost—glaucoma	0.000338	0.00286	CcSEcCtD
Phenylpropanolamine—Agitation—Clonidine—glaucoma	0.000338	0.00286	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Pilocarpine—glaucoma	0.000335	0.00283	CcSEcCtD
Phenylpropanolamine—Somnolence—Pilocarpine—glaucoma	0.000334	0.00282	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Betaxolol—glaucoma	0.000328	0.00278	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Dorzolamide—glaucoma	0.000327	0.00277	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Travoprost—glaucoma	0.000326	0.00276	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Brinzolamide—glaucoma	0.000322	0.00272	CcSEcCtD
Phenylpropanolamine—Constipation—Pilocarpine—glaucoma	0.000321	0.00272	CcSEcCtD
Phenylpropanolamine—Dizziness—Apraclonidine—glaucoma	0.00032	0.00271	CcSEcCtD
Phenylpropanolamine—Tension—Betaxolol—glaucoma	0.000314	0.00266	CcSEcCtD
Phenylpropanolamine—Anxiety—Clonidine—glaucoma	0.000312	0.00264	CcSEcCtD
Phenylpropanolamine—Dizziness—Bimatoprost—glaucoma	0.000311	0.00263	CcSEcCtD
Phenylpropanolamine—Nervousness—Betaxolol—glaucoma	0.000311	0.00263	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Pilocarpine—glaucoma	0.000309	0.00262	CcSEcCtD
Phenylpropanolamine—Vomiting—Apraclonidine—glaucoma	0.000308	0.00261	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Brimonidine—glaucoma	0.000306	0.00259	CcSEcCtD
Phenylpropanolamine—Dermatitis—Apraclonidine—glaucoma	0.000305	0.00258	CcSEcCtD
Phenylpropanolamine—Confusional state—Clonidine—glaucoma	0.000302	0.00256	CcSEcCtD
Phenylpropanolamine—Vision blurred—Betaxolol—glaucoma	0.000301	0.00255	CcSEcCtD
Phenylpropanolamine—Tremor—Betaxolol—glaucoma	0.0003	0.00254	CcSEcCtD
Phenylpropanolamine—Hallucination—Timolol—glaucoma	0.000299	0.00253	CcSEcCtD
Phenylpropanolamine—Rash—Bimatoprost—glaucoma	0.000296	0.00251	CcSEcCtD
Phenylpropanolamine—Dermatitis—Bimatoprost—glaucoma	0.000296	0.00251	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Dorzolamide—glaucoma	0.000293	0.00248	CcSEcCtD
Phenylpropanolamine—Tachycardia—Clonidine—glaucoma	0.000293	0.00248	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Travoprost—glaucoma	0.000291	0.00247	CcSEcCtD
Phenylpropanolamine—Nausea—Apraclonidine—glaucoma	0.000288	0.00244	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Brinzolamide—glaucoma	0.000288	0.00244	CcSEcCtD
Phenylpropanolamine—Dizziness—Acetazolamide—glaucoma	0.000287	0.00243	CcSEcCtD
Phenylpropanolamine—Hypotension—Clonidine—glaucoma	0.00028	0.00237	CcSEcCtD
Phenylpropanolamine—Nausea—Bimatoprost—glaucoma	0.000279	0.00236	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Pilocarpine—glaucoma	0.000277	0.00234	CcSEcCtD
Phenylpropanolamine—Vomiting—Acetazolamide—glaucoma	0.000276	0.00233	CcSEcCtD
Phenylpropanolamine—Dizziness—Brimonidine—glaucoma	0.000275	0.00233	CcSEcCtD
Phenylpropanolamine—Anxiety—Betaxolol—glaucoma	0.000271	0.0023	CcSEcCtD
Phenylpropanolamine—Insomnia—Clonidine—glaucoma	0.000271	0.0023	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Timolol—glaucoma	0.000268	0.00227	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Clonidine—glaucoma	0.000267	0.00226	CcSEcCtD
Phenylpropanolamine—Somnolence—Clonidine—glaucoma	0.000266	0.00226	CcSEcCtD
Phenylpropanolamine—Confusional state—Betaxolol—glaucoma	0.000263	0.00223	CcSEcCtD
Phenylpropanolamine—Dizziness—Dorzolamide—glaucoma	0.000263	0.00222	CcSEcCtD
Phenylpropanolamine—Rash—Brimonidine—glaucoma	0.000262	0.00222	CcSEcCtD
Phenylpropanolamine—Dermatitis—Brimonidine—glaucoma	0.000262	0.00222	CcSEcCtD
Phenylpropanolamine—Dizziness—Travoprost—glaucoma	0.000262	0.00221	CcSEcCtD
Phenylpropanolamine—Dizziness—Brinzolamide—glaucoma	0.000258	0.00219	CcSEcCtD
Phenylpropanolamine—Nausea—Acetazolamide—glaucoma	0.000257	0.00218	CcSEcCtD
Phenylpropanolamine—Tension—Timolol—glaucoma	0.000256	0.00217	CcSEcCtD
Phenylpropanolamine—Constipation—Clonidine—glaucoma	0.000256	0.00217	CcSEcCtD
Phenylpropanolamine—Tachycardia—Betaxolol—glaucoma	0.000255	0.00216	CcSEcCtD
Phenylpropanolamine—Nervousness—Timolol—glaucoma	0.000254	0.00215	CcSEcCtD
Phenylpropanolamine—Vomiting—Dorzolamide—glaucoma	0.000253	0.00214	CcSEcCtD
Phenylpropanolamine—Rash—Dorzolamide—glaucoma	0.00025	0.00212	CcSEcCtD
Phenylpropanolamine—Dermatitis—Dorzolamide—glaucoma	0.00025	0.00212	CcSEcCtD
Phenylpropanolamine—Rash—Travoprost—glaucoma	0.000249	0.00211	CcSEcCtD
Phenylpropanolamine—Dermatitis—Travoprost—glaucoma	0.000249	0.00211	CcSEcCtD
Phenylpropanolamine—Vomiting—Brinzolamide—glaucoma	0.000248	0.0021	CcSEcCtD
Phenylpropanolamine—Dizziness—Pilocarpine—glaucoma	0.000248	0.0021	CcSEcCtD
Phenylpropanolamine—Nausea—Brimonidine—glaucoma	0.000247	0.00209	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Clonidine—glaucoma	0.000247	0.00209	CcSEcCtD
Phenylpropanolamine—Rash—Brinzolamide—glaucoma	0.000246	0.00208	CcSEcCtD
Phenylpropanolamine—Vision blurred—Timolol—glaucoma	0.000246	0.00208	CcSEcCtD
Phenylpropanolamine—Dermatitis—Brinzolamide—glaucoma	0.000246	0.00208	CcSEcCtD
Phenylpropanolamine—Hypotension—Betaxolol—glaucoma	0.000244	0.00206	CcSEcCtD
Phenylpropanolamine—Vomiting—Pilocarpine—glaucoma	0.000239	0.00202	CcSEcCtD
Phenylpropanolamine—Rash—Pilocarpine—glaucoma	0.000237	0.002	CcSEcCtD
Phenylpropanolamine—Dermatitis—Pilocarpine—glaucoma	0.000236	0.002	CcSEcCtD
Phenylpropanolamine—Insomnia—Betaxolol—glaucoma	0.000236	0.002	CcSEcCtD
Phenylpropanolamine—Nausea—Dorzolamide—glaucoma	0.000236	0.002	CcSEcCtD
Phenylpropanolamine—Nausea—Travoprost—glaucoma	0.000235	0.00199	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Betaxolol—glaucoma	0.000233	0.00197	CcSEcCtD
Phenylpropanolamine—Nausea—Brinzolamide—glaucoma	0.000232	0.00196	CcSEcCtD
Phenylpropanolamine—Constipation—Betaxolol—glaucoma	0.000223	0.00189	CcSEcCtD
Phenylpropanolamine—Nausea—Pilocarpine—glaucoma	0.000223	0.00189	CcSEcCtD
Phenylpropanolamine—Anxiety—Timolol—glaucoma	0.000222	0.00188	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Clonidine—glaucoma	0.000221	0.00187	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Betaxolol—glaucoma	0.000215	0.00182	CcSEcCtD
Phenylpropanolamine—Confusional state—Timolol—glaucoma	0.000215	0.00182	CcSEcCtD
Phenylpropanolamine—Hypotension—Timolol—glaucoma	0.000199	0.00169	CcSEcCtD
Phenylpropanolamine—Dizziness—Clonidine—glaucoma	0.000198	0.00168	CcSEcCtD
Phenylpropanolamine—Insomnia—Timolol—glaucoma	0.000193	0.00163	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Betaxolol—glaucoma	0.000192	0.00163	CcSEcCtD
Phenylpropanolamine—Vomiting—Clonidine—glaucoma	0.000191	0.00161	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Timolol—glaucoma	0.00019	0.00161	CcSEcCtD
Phenylpropanolamine—Somnolence—Timolol—glaucoma	0.00019	0.0016	CcSEcCtD
Phenylpropanolamine—Rash—Clonidine—glaucoma	0.000189	0.0016	CcSEcCtD
Phenylpropanolamine—Dermatitis—Clonidine—glaucoma	0.000189	0.0016	CcSEcCtD
Phenylpropanolamine—Nausea—Clonidine—glaucoma	0.000178	0.00151	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Timolol—glaucoma	0.000176	0.00149	CcSEcCtD
Phenylpropanolamine—Dizziness—Betaxolol—glaucoma	0.000173	0.00146	CcSEcCtD
Phenylpropanolamine—Vomiting—Betaxolol—glaucoma	0.000166	0.0014	CcSEcCtD
Phenylpropanolamine—Rash—Betaxolol—glaucoma	0.000165	0.00139	CcSEcCtD
Phenylpropanolamine—Dermatitis—Betaxolol—glaucoma	0.000164	0.00139	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Timolol—glaucoma	0.000157	0.00133	CcSEcCtD
Phenylpropanolamine—Nausea—Betaxolol—glaucoma	0.000155	0.00131	CcSEcCtD
Phenylpropanolamine—Dizziness—Timolol—glaucoma	0.000141	0.00119	CcSEcCtD
Phenylpropanolamine—Vomiting—Timolol—glaucoma	0.000136	0.00115	CcSEcCtD
Phenylpropanolamine—Rash—Timolol—glaucoma	0.000134	0.00114	CcSEcCtD
Phenylpropanolamine—Dermatitis—Timolol—glaucoma	0.000134	0.00114	CcSEcCtD
Phenylpropanolamine—Nausea—Timolol—glaucoma	0.000127	0.00107	CcSEcCtD
Phenylpropanolamine—ADRB1—Signaling Pathways—LRP12—glaucoma	5.07e-05	0.00122	CbGpPWpGaD
Phenylpropanolamine—DRD1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	5.07e-05	0.00122	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.01e-05	0.00121	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Platelet activation, signaling and aggregation—SOD1—glaucoma	4.99e-05	0.0012	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	4.98e-05	0.0012	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—LRP12—glaucoma	4.96e-05	0.0012	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—OPN4—glaucoma	4.93e-05	0.00119	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	4.89e-05	0.00118	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—OPN4—glaucoma	4.82e-05	0.00116	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—PTGFR—glaucoma	4.77e-05	0.00115	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Biological oxidations—GSTT1—glaucoma	4.74e-05	0.00114	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	4.63e-05	0.00112	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	4.63e-05	0.00112	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	4.57e-05	0.0011	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	4.56e-05	0.0011	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—OPN4—glaucoma	4.47e-05	0.00108	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	4.46e-05	0.00108	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—PTGFR—glaucoma	4.44e-05	0.00107	CbGpPWpGaD
Phenylpropanolamine—DRD1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	4.43e-05	0.00107	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—CA1—glaucoma	4.4e-05	0.00106	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—PTGFR—glaucoma	4.34e-05	0.00105	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—SMO—glaucoma	4.26e-05	0.00103	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—CTSA—glaucoma	4.26e-05	0.00103	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—LRP12—glaucoma	4.1e-05	0.00099	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—AMPK Signaling—TP53—glaucoma	4.1e-05	0.00099	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—PTGFR—glaucoma	4.03e-05	0.000972	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—CA2—glaucoma	4.02e-05	0.000971	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	3.98e-05	0.000961	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—SMO—glaucoma	3.96e-05	0.000955	CbGpPWpGaD
Phenylpropanolamine—MAOA—SIDS Susceptibility Pathways—VEGFA—glaucoma	3.93e-05	0.000949	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—OPN4—glaucoma	3.91e-05	0.000944	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	3.9e-05	0.00094	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR ligand binding—EDN1—glaucoma	3.86e-05	0.000932	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	3.85e-05	0.000929	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—LRP12—glaucoma	3.81e-05	0.00092	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Biological oxidations—CYP1B1—glaucoma	3.78e-05	0.000911	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—G alpha (i) signalling events—C3—glaucoma	3.77e-05	0.000909	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	3.72e-05	0.000899	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	3.69e-05	0.00089	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—HEYL—glaucoma	3.64e-05	0.000877	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.53e-05	0.000851	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—PTGFR—glaucoma	3.52e-05	0.00085	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—OPN4—glaucoma	3.52e-05	0.000849	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Platelet activation, signaling and aggregation—FN1—glaucoma	3.47e-05	0.000838	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR ligand binding—EDN1—glaucoma	3.47e-05	0.000838	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—OPN4—glaucoma	3.44e-05	0.00083	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	3.43e-05	0.000827	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR ligand binding—EDN1—glaucoma	3.4e-05	0.00082	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—TGFB2—glaucoma	3.39e-05	0.000819	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR ligand binding—C3—glaucoma	3.37e-05	0.000814	CbGpPWpGaD
Phenylpropanolamine—MAOA—SIDS Susceptibility Pathways—TNF—glaucoma	3.37e-05	0.000813	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CA5A—glaucoma	3.32e-05	0.000802	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—NARFL—glaucoma	3.32e-05	0.000802	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	3.3e-05	0.000796	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	3.3e-05	0.000796	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—HEYL—glaucoma	3.27e-05	0.000789	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	3.22e-05	0.000778	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—HEYL—glaucoma	3.2e-05	0.000772	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—PTGFR—glaucoma	3.17e-05	0.000764	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—PTGFR—glaucoma	3.1e-05	0.000747	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR ligand binding—C3—glaucoma	3.03e-05	0.000732	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Biological oxidations—GSTM1—glaucoma	3.02e-05	0.000729	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—SMO—glaucoma	3.01e-05	0.000725	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.99e-05	0.000723	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	2.98e-05	0.000719	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR ligand binding—C3—glaucoma	2.97e-05	0.000716	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—CA1—glaucoma	2.94e-05	0.000709	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—CTSA—glaucoma	2.85e-05	0.000687	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—OPN4—glaucoma	2.84e-05	0.000687	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—TXN—glaucoma	2.83e-05	0.000684	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—EDN1—glaucoma	2.81e-05	0.000678	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—RPTOR—glaucoma	2.76e-05	0.000665	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—SMO—glaucoma	2.7e-05	0.000652	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—CA2—glaucoma	2.69e-05	0.000649	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—NCK2—glaucoma	2.67e-05	0.000644	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—HEYL—glaucoma	2.64e-05	0.000638	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—SMO—glaucoma	2.64e-05	0.000638	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—OPN4—glaucoma	2.64e-05	0.000638	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—EDN1—glaucoma	2.61e-05	0.00063	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—SOD1—glaucoma	2.57e-05	0.000621	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—PTGFR—glaucoma	2.56e-05	0.000618	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—RPTOR—glaucoma	2.48e-05	0.000598	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—HEYL—glaucoma	2.46e-05	0.000593	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—C3—glaucoma	2.45e-05	0.000592	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—RPTOR—glaucoma	2.42e-05	0.000585	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—NCK2—glaucoma	2.4e-05	0.000579	CbGpPWpGaD
Phenylpropanolamine—DRD1—Circadian rythm related genes—TP53—glaucoma	2.4e-05	0.000578	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—PTGFR—glaucoma	2.38e-05	0.000574	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—NCK2—glaucoma	2.35e-05	0.000566	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—C3—glaucoma	2.28e-05	0.00055	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—HDAC9—glaucoma	2.27e-05	0.000548	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—GSTT1—glaucoma	2.2e-05	0.00053	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—SMO—glaucoma	2.19e-05	0.000528	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—EDN1—glaucoma	2.18e-05	0.000527	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—HDAC9—glaucoma	2.04e-05	0.000492	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—SMO—glaucoma	2.03e-05	0.00049	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—RPTOR—glaucoma	2e-05	0.000484	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—HDAC9—glaucoma	2e-05	0.000482	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—glaucoma	1.99e-05	0.00048	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—EDN1—glaucoma	1.98e-05	0.000478	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—EDN1—glaucoma	1.96e-05	0.000473	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—MMP1—glaucoma	1.96e-05	0.000473	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—NCK2—glaucoma	1.94e-05	0.000468	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—EDN1—glaucoma	1.92e-05	0.000463	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—C3—glaucoma	1.91e-05	0.00046	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—TXN—glaucoma	1.89e-05	0.000457	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—CAV1—glaucoma	1.88e-05	0.000454	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—RPTOR—glaucoma	1.86e-05	0.000449	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NCK2—glaucoma	1.8e-05	0.000435	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—FN1—glaucoma	1.79e-05	0.000432	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—EDN1—glaucoma	1.78e-05	0.00043	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—SMO—glaucoma	1.78e-05	0.000429	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—ABCA1—glaucoma	1.75e-05	0.000423	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—CYP1B1—glaucoma	1.75e-05	0.000423	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—EDN1—glaucoma	1.74e-05	0.000421	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—C3—glaucoma	1.73e-05	0.000418	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—C3—glaucoma	1.71e-05	0.000414	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—C3—glaucoma	1.68e-05	0.000405	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—HDAC9—glaucoma	1.65e-05	0.000398	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—NTRK2—glaucoma	1.62e-05	0.000392	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CA1—glaucoma	1.62e-05	0.000392	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—SMO—glaucoma	1.6e-05	0.000385	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—EDN1—glaucoma	1.59e-05	0.000383	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CTSA—glaucoma	1.57e-05	0.000379	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—SMO—glaucoma	1.56e-05	0.000377	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—C3—glaucoma	1.56e-05	0.000376	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—HDAC9—glaucoma	1.53e-05	0.00037	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—C3—glaucoma	1.52e-05	0.000367	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CA2—glaucoma	1.48e-05	0.000358	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—EDN1—glaucoma	1.47e-05	0.000356	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—GSTT1—glaucoma	1.47e-05	0.000354	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—NTRK2—glaucoma	1.46e-05	0.000352	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.45e-05	0.00035	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.45e-05	0.00035	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—EDN1—glaucoma	1.44e-05	0.000348	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—NTRK2—glaucoma	1.43e-05	0.000345	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—NOS3—glaucoma	1.42e-05	0.000343	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—GSTM1—glaucoma	1.4e-05	0.000338	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—NGFR—glaucoma	1.39e-05	0.000336	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—C3—glaucoma	1.39e-05	0.000335	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—EDN1—glaucoma	1.34e-05	0.000323	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—NTRK1—glaucoma	1.32e-05	0.000319	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—SMO—glaucoma	1.29e-05	0.000312	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—C3—glaucoma	1.29e-05	0.000311	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—C3—glaucoma	1.26e-05	0.000304	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—NGFR—glaucoma	1.25e-05	0.000302	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—MTHFR—glaucoma	1.24e-05	0.000299	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—NGFR—glaucoma	1.23e-05	0.000296	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CDKN2B—glaucoma	1.22e-05	0.000294	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—SMO—glaucoma	1.2e-05	0.00029	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—NTRK1—glaucoma	1.19e-05	0.000287	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—NTRK2—glaucoma	1.18e-05	0.000285	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—EDN1—glaucoma	1.17e-05	0.000283	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—C3—glaucoma	1.17e-05	0.000282	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—ABCA1—glaucoma	1.17e-05	0.000282	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—CYP1B1—glaucoma	1.17e-05	0.000282	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—NTRK1—glaucoma	1.16e-05	0.000281	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—APOE—glaucoma	1.15e-05	0.000278	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—CAV1—glaucoma	1.14e-05	0.000275	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NTRK2—glaucoma	1.1e-05	0.000265	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CDKN2B—glaucoma	1.1e-05	0.000265	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—NGF—glaucoma	1.08e-05	0.00026	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CDKN2B—glaucoma	1.07e-05	0.000259	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—EDN1—glaucoma	1.05e-05	0.000254	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—TXN—glaucoma	1.05e-05	0.000252	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—EDN1—glaucoma	1.03e-05	0.000248	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—VEGFA—glaucoma	1.02e-05	0.000247	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—C3—glaucoma	1.02e-05	0.000247	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—NGFR—glaucoma	1.01e-05	0.000245	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—NGF—glaucoma	9.67e-06	0.000233	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—NTRK1—glaucoma	9.63e-06	0.000232	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.54e-06	0.00023	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—APOE—glaucoma	9.52e-06	0.00023	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—NGF—glaucoma	9.46e-06	0.000228	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.45e-06	0.000228	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CAV1—glaucoma	9.43e-06	0.000228	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NGFR—glaucoma	9.42e-06	0.000227	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—GSTM1—glaucoma	9.35e-06	0.000226	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—C3—glaucoma	9.19e-06	0.000222	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—C3—glaucoma	8.99e-06	0.000217	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—FN1—glaucoma	8.98e-06	0.000217	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NTRK1—glaucoma	8.95e-06	0.000216	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CDKN2B—glaucoma	8.87e-06	0.000214	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—BAD—glaucoma	8.87e-06	0.000214	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—NOS3—glaucoma	8.63e-06	0.000208	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—APOE—glaucoma	8.56e-06	0.000207	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—EDN1—glaucoma	8.51e-06	0.000206	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CAV1—glaucoma	8.48e-06	0.000205	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—APOE—glaucoma	8.37e-06	0.000202	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CAV1—glaucoma	8.29e-06	0.0002	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—MTHFR—glaucoma	8.27e-06	0.000199	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CDKN2B—glaucoma	8.24e-06	0.000199	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—GSTT1—glaucoma	8.11e-06	0.000196	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—FN1—glaucoma	8.07e-06	0.000195	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—BAD—glaucoma	7.98e-06	0.000192	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—EDN1—glaucoma	7.91e-06	0.000191	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—FN1—glaucoma	7.9e-06	0.000191	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—PTGS2—glaucoma	7.89e-06	0.00019	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—NGF—glaucoma	7.82e-06	0.000189	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—BAD—glaucoma	7.8e-06	0.000188	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—TP53—glaucoma	7.74e-06	0.000187	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—APOE—glaucoma	7.69e-06	0.000186	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—CAV1—glaucoma	7.62e-06	0.000184	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—C3—glaucoma	7.44e-06	0.00018	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NGF—glaucoma	7.27e-06	0.000175	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—NOS3—glaucoma	7.13e-06	0.000172	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—APOE—glaucoma	6.92e-06	0.000167	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—C3—glaucoma	6.91e-06	0.000167	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CAV1—glaucoma	6.86e-06	0.000166	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.54e-06	0.000158	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—FN1—glaucoma	6.53e-06	0.000158	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ABCA1—glaucoma	6.46e-06	0.000156	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CYP1B1—glaucoma	6.46e-06	0.000156	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—BAD—glaucoma	6.45e-06	0.000156	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—APOE—glaucoma	6.43e-06	0.000155	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—NOS3—glaucoma	6.41e-06	0.000155	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CAV1—glaucoma	6.37e-06	0.000154	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—NOS3—glaucoma	6.27e-06	0.000151	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CDKN1B—glaucoma	6.18e-06	0.000149	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—FN1—glaucoma	6.07e-06	0.000146	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—BAD—glaucoma	6e-06	0.000145	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—NOS3—glaucoma	5.76e-06	0.000139	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—MMP9—glaucoma	5.72e-06	0.000138	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CDKN1B—glaucoma	5.55e-06	0.000134	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CDKN1B—glaucoma	5.43e-06	0.000131	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—PTGS2—glaucoma	5.27e-06	0.000127	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—NOS3—glaucoma	5.19e-06	0.000125	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—GSTM1—glaucoma	5.16e-06	0.000125	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—MMP9—glaucoma	5.14e-06	0.000124	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—VEGFA—glaucoma	5.14e-06	0.000124	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—MMP9—glaucoma	5.03e-06	0.000121	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NOS3—glaucoma	4.82e-06	0.000116	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—VEGFA—glaucoma	4.62e-06	0.000111	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—MTHFR—glaucoma	4.56e-06	0.00011	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—VEGFA—glaucoma	4.52e-06	0.000109	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CDKN1B—glaucoma	4.49e-06	0.000108	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—APOE—glaucoma	4.25e-06	0.000103	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CAV1—glaucoma	4.21e-06	0.000102	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CDKN1B—glaucoma	4.18e-06	0.000101	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—MMP9—glaucoma	4.16e-06	0.0001	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—TP53—glaucoma	3.88e-06	9.37e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—MMP9—glaucoma	3.87e-06	9.33e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—VEGFA—glaucoma	3.74e-06	9.02e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—TP53—glaucoma	3.49e-06	8.42e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—VEGFA—glaucoma	3.47e-06	8.38e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—TP53—glaucoma	3.41e-06	8.24e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—NOS3—glaucoma	3.18e-06	7.68e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PTGS2—glaucoma	2.91e-06	7.02e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—TP53—glaucoma	2.82e-06	6.82e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—TP53—glaucoma	2.62e-06	6.33e-05	CbGpPWpGaD
